Preparation and characterization of a recombinant humanized single- chain Fv antibody/human interleukin-2 fusion protein directed against the HER-2/neu (c-erbB2) proto-oncogene product, p185

Tumor Targeting

Volumn 4, Issue 2, 1999, Pages 105-114

  Li, J ^a   Gyorffy, S F ^a   Ring, D B ^a   Kwok, C S ^a   Austin, R C ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Fusion protein; HER 2 neu (c erbB2) proto oncogene; Humanized sFv; Interleukin 2

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; IMMUNE RESPONSE; KIDNEY CARCINOMA; MELANOMA; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTO ONCOGENE;

EID: 0032844811     PISSN: 13518488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)